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INTRODUCTION
Rickets is a common nutritional health problem in
children. Nutritional rickets causes considerable
childhood morbidity, disability and remains prevalent in
the developing countries of Asia. It is still present in
Pakistan’s urban economically  and rural deprived
areas.1,2 It is unclear why rickets is so prevalent in
tropical countries with abundant sunlight which should
prevent vitamin-D deficiency. Its etiology is multifactorial
including inadequate dietary intake of vitamin-D,
reduced vitamin-D production in dark pigmented skin,
inadequate sun exposure because of air pollution,
infants remaining indoors, cereal-based diet with high
phytate content, malabsorption, rapid growth of healthy
infant, prematurity and low-birth weight, vitamin-D
malnutrition in pregnant and lactating mothers and
prolonged therapy with anticonvulsant and genetic
factors.3-15 Children with nutritional rickets need
treatment to prevent them from severe consequences of
rickets. The standard treatment16 for nutritional rickets is
vitamin-D. Dietary Cholecalciferol (D3) and supple-
mental sources are important in prevention and
treatment of rickets in children. We conducted a
longitudinal case control study to compare the efficacy
of injectable vitamin-D (cholecalciferol) with single dose
oral vitamin-D, assess the safety and efficacy of it.
METHODOLOGY
This study was conducted at the Paediatric Outpatient
Department of Kharadar General Hospital, Karachi, from
August 2003 to April 2004. This was a clinical trial in
which 100 cases were enrolled. All children from 6
months to 3 years of age with clinical, biochemical and
radiological evidence of vitamin-D deficiency rickets
were included. Children under 6 months or more than 3
years of age, severely malnourished children with
rickets other than nutritional type, or presenting with
congenital abnormalities, serious illness during the
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study as follow-up or known hypersensitivity to the
product were excluded. After taking informed consent
from the parents, history and clinical examination was
done and complete blood picture, serum calcium,
phosphorus, alkaline phosphatase, and X-ray of wrist
joint were done and findings were recorded on
performa. Radiological criteria used to define active
rickets were osteopenia (bone demineralization),
widening of growth plate and metaphyseal cupping.17,18
Active rickets was further divided in florid and non-florid
type.13 Radiological evidence of healing was defined as
the presence of new calcification, reduced widening of
the growth plate compared with the baseline
radiograph.17,18 The children were divided into two
groups by stratified sampling. Children of group-A were
given vitamin-D (cholecalciferol) 200,000 i.u orally on
the day of induction (Do) in the study and children
assigned to group-B were given vitamin-D
(cholecalciferol) 200,000 i.u by intramuscular injection.
All children were further followed up for two more visits
on thirty (D30) and ninty (D90) days. In the follow-up visits
the children were subjected to clinical, biochemical and
radiological examination and their findings were
recorded. For statistical analysis, ANOVA (repeated
measured test) was applied to measure the statistical
difference of values in weight, height, hemoglobin and
biochemical results of first and follow-up visits. Pearson
Chi-square was applied to assess the radiological
findings of all patients in both groups. P-value <0.05 was
considered as statistically significant.
RESULTS
At the end of the study, the data was analyzed and
following observations were recorded. Hundred children
were enrolled, 50 in group A (oral) and 50 in group B
(injectable) according to the study inclusion criteria.
Ninety-six percent of children from group A and 94%
from group B completed the full study period. Two
patients from group A and 3 patients from group B were
lost during follow-up.
Baseline characteristics like age, gender, weight and
height are shown in Table I. Weight gain in both groups
is statistically significant and same in both groups, while
increase in height is statistically significant in group B
(injectable group). The symptoms and signs of both
groups are shown in Table II. The predominant symptom
was weakness (78-84%) and difficulty in walking
(74-78%) while signs like frontal bossing, ribcage
deformity and widening of wrists were predominant. The
hematological and biochemical  findings of both groups
were compared as shown in Table III. Regarding
hematological investigations, the level  of  hemoglobin
improved and biochemically, the level of alkaline
phosphatase activity in both the groups became normal
during the follow-up  period (Table IV). Statistically, the
level of calcium was raised in both the groups
significantly, while alkaline phosphatase level was
reduced in both groups but more (p<0.01) in group B.
Radiologically, 58.3% cases in group-A and 59.57% in
group-B had shown active florid rickets before
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Table I: Baseline characteristics of both groups (oral and injectable
vitamin-D).
Characteristics Group A P-value/ratio Group B P-value/ratio
(oral) (injectable)
Age (months)
Mean+S.D 10.9+5.1 14.7+8.1
Range 24 (6-30) 28 (6-34) ----
Gender
Male 36 1:0.39 27 
Female 14 23 1:0.85
Weight (Kg)
Day 1 7.6+1.5 0.012* 8.1+2.0
Day 30th 7.9+1.5 8.7+2.0
Day 90th 8.6+1.4 9.0+2.0 0.027*
Height (cm)
Day 1 67.0+5.8 0.056** 68.9+7.0
Day 30th 66.6+10.9 71.6+7.4
Day 90th 71.0+5.9 73.4+7.1 0.018*
*=Statistically significant at p<0.05;  **=Not significant.
Table II: Symptoms and signs of both groups.
Symptoms Group A (Oral) Group B (Injectable)
Weakness 42 (84%) 39 (78%)
Frequency of fall 11 (22%) 09 (18%)
Difficulty in walking 37 (74%) 39 (78%)
Leg pain during walking 07 (14%) 07 (14%)
Signs
Bossing of forehead 32 (64%) 28 (56%)
Wide anterior fontanel 26 (52%) 21 (42%)
Rib cage deformity 29 (58%) 33 (66%)
Harrison sulcus 16 (32%) 11 (22%)
Widening of wrist 37 (74%) 41 (82%)
Genu varum 05 (10%) 07 (14%)
Genu valgum 23 (46%) 27 (54%)
Widening of  ankle 11 (22%) 10 (20%)
Table III: Hematological and biochemical findings of both groups (oral
and injectable vitamin-D).
Group A P-value Group B P-value
Mean +SD
A.
Hematological  
Hemoglobin (gm%) 9.4+1.2 9.3+1.4
B.
Biochemical findings
I.  Serum calcium
Day 1 8.7+0.9 8.2+1.2
Day 30th 8.9+0.8 0.2277** 8.7+1.0 0.026*
Day 90th 8.8+0.7 8.7+0.9
II. Serum phosphorus
Day 1 4.6+1.7 4.7+1.5
Day 30th 5.5+1.1 0.317** 5.0+1.0 0.898**
Day 90th 5.1+0.9 4.9+1.1 
III. Alkaline phosphatase
Day 1 580+409 687+498
Day 30th 385+201 0.013* 469+314 0.009*
Day 90th 295+71 309+149
*= Statistically significant  p<0.05;   **= Not significant
Serum Calcium: 8.1-10.4mg/dl, Phosphorus: 4-7mg/dl,
Alkaline phosphatase: male (105-289 i.u), Female (97-278 i.u)
administration of therapy and all of them showed signs
of healed rickets during their subsequent visits.
Regarding the route of administration of vitamin-D
(cholecalciferol), it was seen that the parents preferred
the injectable route. There were no undesirable side
effects observed in either groups and both oral and
injectable forms of the treatment were well-tolerated.
DISCUSSION
In this study, the clinical efficacy of injectable versus oral
form of cholecalciferol was compared. There were 50
children in each group. The average age in this study
was 10.9+5.1 months in group A and 14.7+8.1 months
in group B. In a local study from Lahore, age of rickets
children were in the range of 6-11 months.19 In African
country – Ethiopia, rickets children were 6-18 months20
while in Middle East country – Kuwait, the children were
under one year.21 The male to female ratio was 1:0.4
and 1:0.9 in group A and B respectively. Preponderance
of male children in both groups was observed as seen in
one of the study from Karachi2 with 62% of male, and in
Peshawar,6 the male children were 62%, while a study
from Lahore,19 recognised male gender as a risk factor.
Kharadar General Hospital is located in the old city area
of Karachi and comprises of a population of mostly
lower and middle classes. The majority of population live
in multi-storied congested apartments or small houses
with one or two rooms devoid of sunlight and without
any courtyards. The women and children wear the local
dress (shalwar kameez), which covers   most of the skin
surfaces except face and hands. The body charac-
teristics like weight and height showed  improvement as
compared to  their first  visit  prior  to oral  or  injectable
dose of vitamin-D (as shown in Table I). In clinical
symptoms and signs, the majority of parents/guardians
highlighted the symptoms of weakness which is difficult
to explain in young infants, possibly it is attributed to
hypotonia, which is seen in rickets. Progressive
weakness of proximal muscles is a feature of rickets.22
Difficulty in walking, frequent falls, pain in the hands and
legs were seen,23 while in signs widening of wrists,
frontal bossing, wide anterior fontanel and rib cage
deformity were predominantly seen. An additional
observation was the hemoglobin level improved as
compared to the level prior to the administration of
vitamin D (cholecalciferol). A high  degree of association
between iron deficiency anemia and vitamin-D
deficiency has been observed.24 Low plasma vitamin D
and iron deficiency anaemia often coexist.25 Iron
deficiency  was  found to be a significant  risk factor for
low  vitamin-D. Alkaline phosphatase level  remains a
reliable and economic biochemical marker for
diagnosing vitamin-D deficiency  rickets  and  monitoring
the  effectiveness  of  treatment  in the  clinical setting.26
Radiologically, all cases of rickets (florid or non-florid)
showed healed rickets  during  their  subsequent visits.
There were no undesirable side effects observed in
either group of children and  both oral and injectable
forms of treatment were well-tolerated. Cost of oral and
injectable vitamin-D was almost same. Regarding route
of administration of cholecalciferol, the parents
preferred intramuscular route.
CONCLUSION
Vitamin-D (cholecalciferol) is effective in the treatment of
nutritional vitamin-D rickets in both intramuscular   and
oral form. The clinical efficacy of vitamin-D (cholecal-
ciferol) by both routes is equaly good and there are no
side effects in either form. Oral vitamin-D (cholecal-
ciferol; 200,000 i.u) is as effective in the  treatment of
nutritional vitamin-D deficiency rickets as injectable.
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